Key Highlights
- ACMR shares rose 7.81% pre-market to $42.38 after closing at $39.31 on Nov. 5.
- Q3 Revenue rose 36.6% to $367.7 million; non-GAAP EPS was $0.55.
- Full-year 2026 revenue guidance was raised to $1.24 billion to $1.28 billion.
- Backlog reached $2.5 billion, up 88% year over year.
ACM Research (NASDAQ:ACMR) shares were up 7.81% pre-market at $42.38, compared with a Nov. 5 close of $39.31, after the company reported third-quarter 2026 results and raised its full-year revenue guidance. Revenue rose 36.6% to $367.7 million, compared with an analyst estimate of $310.6 million, and non-GAAP EPS was $0.55 against an estimate of $0.51.
ACM Research, based in Fremont, California, develops, manufactures and sells single-wafer wet cleaning systems and other wafer fabrication equipment, including electro-chemical plating, furnace and advanced packaging tools, marketed under the Ultra C brand. It runs its operations mainly through ACM Research (Shanghai).
Revenue Up 36.6% With Shipments of $343.5 Million and a 41.6% Gross Margin
Shipments were $343.5 million, up 30.6%. Gross Margin was 41.6% versus 42.1%, below the long-term target range of 42% to 48%, and Operating Margin was 18.0% versus 13.6%. Non-GAAP EPS was $0.55 versus $0.41, GAAP Net Income was $1.5 million and net cash was $0.9 billion.
Segment revenue growth was led by ECP, furnace and other at 83% and advanced packaging at 71%. Cleaning grew 16% and was 57% of revenue, and ACM is on track to ship more than 20 single-wafer SPM tools in 2026.
2026 Revenue Guidance Raised to $1.24 Billion to $1.28 Billion With Backlog at $2.5 Billion
Full-year 2026 revenue guidance was raised to $1.24 billion to $1.28 billion, up 38% to 42% year over year, from $1.125 billion to $1.175 billion. Backlog reached $2.5 billion, up 88% year over year, and year-to-date orders were up 147%. Fourth-quarter shipments are expected to exceed the third quarter, and fourth-quarter gross margin is expected to improve modestly. The long-term revenue target is $4 billion.
For 2026, management guides to R&D of 15% to 17% of sales, sales and Marketing of 7% to 8%, G&A of about 5%, a tax rate of about 10% and capex of about $175 million.
New Products Move Toward Commercialization in 2027 as the Selloff Weighs on Shares
New products are expected to move from evaluation to commercialization in 2027, including panel-level horizontal plating, with the first 310x310mm shipment in October, along with track, PECVD and furnace. Lingang's second building is ramping, and the two buildings can support up to $3 billion in annual output. About 10 customers across 5 countries are outside mainland China, with more than 20 tools installed outside mainland China by year-end and an Oregon Facility opening soon.
On Nov. 5, shares closed down 11.52% at $39.31 as the Philadelphia Semiconductor index fell 12.3%, its worst day since March 2020. Roth Capital cut its price target to $60 from $125. ACM Research has a forward P/E of 14.19, a trailing P/E of 24.57 and EPS of $1.49, with a 52-week range of $28.46 to $127.19.
Next Up: Fourth-Quarter Shipments and the 2027 Commercialization of New Products
ACM Research shares are higher pre-market after third-quarter revenue of $367.7 million, raised 2026 guidance and a $2.5 billion backlog. Attention turns to fourth-quarter shipments expected to exceed the third quarter, the modest gross margin improvement expected in the fourth quarter and the move of new products toward commercialization in 2027.
_11_20_2026_20_16_27_766407.jpg)





Please wait processing your request...